Effect of addition of FSH, LH and proteasome inhibitor MG132 to in vitro maturation medium on the developmental competence of yak (Bos grunniens) oocytes
© Xiao et al.; licensee BioMed Central Ltd. 2014
Received: 20 February 2014
Accepted: 14 April 2014
Published: 22 April 2014
The competence for embryonic development after IVF is low in the yak, therefore, we investigated the effects of supplementation of FSH, LH and the proteasome inhibitor MG132 in IVM media on yak oocyte competence for development after IVF.
In Experiment 1, yak cumulus-oocyte complexes (COCs) were in vitro matured (IVM) in TCM-199 with 20% fetal calf serum (FCS), 1 microg/mL estradiol-17beta, and different combinations of LH (50 or 100 IU/mL) and FSH (0, 1, 5, 10 microg/mL) at 38.6 degrees C, 5% CO2 in air for 24 h. Matured oocytes were exposed to frozen–thawed, heparin-capacitated yak sperm. Presumptive zygotes were cultured in SOF medium containing 6 mg/ml BSA, 0.5 mg/mL myoinositol, 3% (v/v) essential amino acids, 1% nonessential amino acids and 100 μg/mL L-glutamine (48 h, 38.5 degrees C, 5% CO2, 5% O2, and 90% N2). In Experiment 2, cumulus cells were collected at the end of IVM to determine FSHR and LHR mRNA expression by real-time PCR. In Experiment 3 and 4, COCs were cultured in the presence or absence of the proteasomal inhibitor MG132 from either 0–6 h or 18–24 h after initiation of maturation.
The optimum concentration of FSH and LH in IVM media was 5 microg/mL FSH and 50 IU/mL LH which resulted in the greatest cleavage (79.1%) and blastocyst rates (16.1%). Both FSHR and LHR mRNA were detected in yak cumulus cells after IVM. Treatment with MG132 early in maturation reduced (P < 0.05) cleavage and blastocyst rates. Conversely, treatment with MG132 late in maturation improved (P < 0.05) blastocyst rate. Optimal results with MG132 were achieved at a concentration of 10 microM.
An optimum concentration of FSH and LH in IVM medium, and treatment with MG132 late in maturation can improve yak oocytes competence for development after IVF.
In most mammals, throughout follicular development, the oocytes undergo a series of profound changes involving both nuclear and cytoplasmic maturation induced by the pre-ovulatory surge of gonadotropins during this period . These changes are essential for the formation of oocytes having the capacity for fertilization and embryonic development. Therefore, in vitro culture systems of most species often occur in in vitro maturation (IVM) media supplemented with gonadotrophins such as FSH and LH to induce cumulus cell expansion, nuclear maturation, cytoplasmic maturation, and to improve embryonic development in mice [2, 3], pig , cow , equine  and domestic dog . For gonadotrophins to act in vitro, FSH and LH receptor (FSHR and LHR) proteins and mRNA must be expressed by the cumulus cell . The proteasome, a multisubunit proteolytic complex involved in degradation of ubiquitinated proteins, plays a crucial role in assuring completion of meiosis and early in maturation of oocyte, however, late in the process of oocyte maturation, the proteasome may contribute to a reduction in the functional properties of the oocyte. Treatment with the proteasome inhibitor MG132 reduced the effect of in vitro aging on oocyte competence in the mouse . Furthermore, treatment of oocytes with MG132 late in maturation increased abundance of specific transcripts and improved developmental competence of parthenogenetically-activated oocytes in the pig  and in vitro matured oocytes in cattle .
The yak (Bos grunniens) is the principal meat and dairy animal in Qinghai-Tibet plateau, because few other animals survive in these areas . In vitro production (IVP) of embryos is a well-established embryonic biotechnology with a variety of application in basic and applied sciences. IVP has been made great progress in cattle which is becoming one of the most exciting and progressive procedures available for today’s producers but the efficiency of yak IVP is still low, i.e. less than 10% of cleaved embryos (i.e., that were ≥2 cells) becoming blastocysts [13, 14]. Therefore, this study was performed to investigate the effect of FSH, LH and MG132 during oocytes maturation on competence for development after fertilization in the yak.
Dulbecco’s phosphate-buffered saline (DPBS) was purchased from Hyclone Laboratories Inc. (Logan, UT), FSH from Bioniche Inc. (Belleville, Ontario, Canada) and fetal calf serum (FCS) from Gibco (Grand Island, NY). All other chemicals and reagents were cell-culture tested and were obtained from Sigma-Aldrich (St. Louis, MO). Synthetic oviductal fluid (SOF) medium was prepared according to the formula of Tervit et al. minus glucose. All media were filtered through 0.2 μm Millipore filter (Carrigtwohill, Co. Cork, Ireland) and placed in an incubator (Forma Serial II, USA) to equilibrate for four to six hours in an atmosphere of 5% CO2 in air.
Oocyte collection and in vitro maturation (IVM)
Collection and IVM of yak oocytes were performed in accordance with the method of Zi et al. [13, 16]. Briefly, ovaries were collected from yaks at local abattoir from October to December, and transported to the laboratory in DPBS maintained at 29–33°C. Cumulus-oocyte complexes (COCs) were aspirated from follicles (2–8 mm diameter) using a hand-held 10-ml syringe connected to an 18 ga needle. COCs were collected in DPBS supplemented with 6 mg/ml BSA under a low-power (20×) stereomicroscope. Unselected COCs were rinsed three times in DPBS containing 5% (v/v) FCS and twice in TCM 199 supplemented with 20% (v/v) FCS, 1 μg/ml estradiol-17β, 100 U/ml penicillin and 100 μg/ml streptomycin, different concentrations of FSH and LH according to the experimental design (IVM medium). Only COCs having one or more layers of cumulus cells and evenly granulated ooplasm were selected. Up to 30 COCs were placed in each culture well (Nunc Inc., Naperville IL, USA) containing 600 μl of maturation medium covered with 300 μl mineral oil. COCs were allowed to mature for approximately 24 h at 38.6°C in an atmosphere of 5% CO2 in humidified air.
Sperm preparation, in vitro fertilization, and embryo culture
Sperm preparation and IVF were conducted according to previously described procedures [13, 16] with some modifications. Frozen semen was thawed and washed by centrifugation through a Percoll gradient (30%/45%) containing Hepes-buffered SOF medium supplemented with 5 mg/ml BSA, 50 μg/ml caffeine, 30 μg/ml glutathione and 20 μg/ml heparin (sperm medium) and centrifuged at 500 × g for 10 min to separate motile sperm. After centrifugation, 120 μl of the concentrated sperm fraction was removed and placed into 200 μl of sperm medium and incubated at 38.6°C for 15 min.
After oocyte maturation, excess cummulus cells were removed by gently swirling the COCs in a 36 mm Petri dish containing SOF with 6 mg/ml BSA (IVF medium). The COCs were further washed twice in IVF medium before being transferred into four-well plates (up to 30 per well) containing 500 μl IVF medium covered with 300 μl mineral oil per well. Each well received 50 μl of the sperm suspension (for a final concentration of 1 × 106 motile sperm/ml). Oocytes and sperm were allowed to coincubate for 24–26 h at 38.6°C in an atmosphere of 5% CO2 in humidified air. Remnant cumulus cells were removed from the putative zygotes by gentle pipetting after approximately 26 h of coincubation. The putative zygotes were then washed three times in SOF medium. Groups of 25 embryos were cultured in 600 μl of SOF medium supplemented with 6 mg/ml BSA, 0.5 mg/ml myoinositol, 3% (v/v) essential amino acids, 1% (v/v) nonessential amino acids, 100 U/ml penicillin, 100 μg/ml streptomycin and 100 μg/ml L-glutamine (culture medium) under 300 μl mineral oil, cultured in a humidified atmosphere of 5% CO2, 5% O2, and 90% N2 at 38.5°C. The number of zygotes that cleaved was recorded 48 h post insemination (hpi). The culture medium was changed at 96 hpi and blastocyst development was determined on Days 7 to 9 post insemination (Day 0 = insemination). This experiment was replicated three to five times for each group.
Expression of FSHR and LHRin cumulus cells after in vitro maturation
GAPDH gene was chosen as reference gene for normalizing expression levels of target genes. Primers specific for target goat genes were designed with Beacon Designer 7.0 software (Premier Biosoft International, Palo Alto, CA USA) according to manufacturers guidelines (FSHR: 5'-TTCAATGGGACAACGCTGATTTC-3'/5'-TGTGGCAATTAGCGTCTGAATG GA-3'; LHR: 5'-AGTGACACCAAGATAGCCAAGC-3/5-GGTAGAACAGGACCAGGAGG AT-3'; GAPDH: 5'-AGTTCCACGGCACAGTCAAG-3'/5'-ACTCAGCACCAGCATCACC- 3'). Total RNA of cumulus cells after in vitro maturation (different concentrations of FSH and LH in IVM medium) was extracted, and reverse transcribed as described previously . Real-time PCR was performed using on an iCycler iQ5 Real-time Detection System (Bio-Rad, CA, USA) with the SsoFast™ EvaGreen Supermix (Bio-Rad, CA, USA) in a volume of 10 μl. The cycle parameters were 3 min at 95°C, followed by 45 cycles of denaturation at 95°C for 10 s and annealing at 60.7°C (FSHR), 58.9°C (LHR) or 57.7°C (GAPDH) for 10 s, and finally, melt curve analysis. The real-time PCR amplification efficiency (E) of each primer pair and mean Ct (threshold cycles) values were calculated and used for determination of target gene RNA transcript levels , which includes a correction for differences in E between the target and housekeeping gene. Results were expressed, however, as relative expression ratios (RE) rather than as fold changes from a calibrator sample. The formula, therefore, was as RE = (1 + E ref) Ct ref /(1 + E target) Ct target . Each sample was tested in triplicate, and each experiment was replicated four times with cumulus cells from 30–50 COCs for each replicate.
Experiment 1 was conducted to investigate the optimal concentration of FSH and LH in IVM medium to improve yak oocyte competence for development after fertilization. COCs were matured in IVM medium that was supplemented with different combinations of LH (50 or 100 IU/ml) and FSH (0, 1, 5, 10 μg/ml).
Experiment 2 was conducted to investigate the effect of addition of FSH and LH in IVM media on FSHR and LHR mRNA expression in cumulus cells after 24 h IVM. COCs were matured in IVM medium that was supplemented with different combinations of LH (0, 50 or 100 IU/ml) and FSH (0, 1, 5, 10 μg/ml). Cumulus cells were collected at the end of IVM for each combination to determine FSHR and LHR mRNA expression.
Experiment 3 was conducted to investigate the concentration-dependent effects of MG132 added at the end of oocyte maturation on embryonic development. The MG132 was dissolved in dimethyl sulfoxide (DMSO) and was added to maturation drops so that the final concentration of DMSO was not greater than 0.5% (v/v). The control oocytes were cultured with medium supplemented with a similar amount of DMSO during IVM as for oocytes treated with MG132. COCs were matured in IVM medium (containing 5 μg/ml FSH and 50 IU/ml LH) that was supplemented with 0, 10, 20 or 30 μM MG132 from 18 h to 24 h after initiation of maturation. Treatment was achieved by washing COCs after 18 h of maturation and placing them in fresh medium containing MG132.
Experiment 4 was conducted to determine whether timing of MG132 treatment altered effects of the inhibitor on embryonic development. COCs were untreated or treated with 10 μM MG132 at two times [0–6 h of maturation (during the initiation of maturation) or 18–24 h of maturation (at the end of maturation)] using a 2 × 2 factorial arrangement of treatments. The COCs were placed in appropriate treatments at 0 h (MG132), washed at 6 h, placed in fresh IVM medium (containing 5 μg/ml FSH and 50 IU/ml LH) without MG132, washed at 18 h of maturation, and placed in fresh medium with appropriate treatment. Thus, some cultures received MG132 at 0–6 h and 18–24 h, some received MG132 from 0–6 h only, some received MG132 from 18–24 h only, and some did not receive MG132 treatment during in vitro maturation.
Data were analyzed statistically as follows. For each replicate, percentage of oocytes that cleaved and percentage of cleaved embryos that became blastocysts were calculated for all oocytes or embryos within the same treatment. Thus, the group of oocytes treated alike within each replicate was the experimental unit. Statistical analyses were performed using the Statistical Analysis System (version 9.2, SAS Institute Inc., Cary, NC, USA). Data were analyzed using the General Linear Models procedure. Percentage data were arcsine- transformed prior to analysis to maintain homogeneity of variance. Results are expressed as least-squares means ± standard error (SE) of the untransformed data.
The optimal concentration of FSH and LH in IVM medium (Experiment 1)
Effects of FSH and LH concentration in IVM medium on yak embryonic development
No. of oocytes
Cleavage rate (%)
Blastocyst rate (%)
50.6 ± 2.2a
10.3 ± 1.8a
73.1 ± 2.9b
11.9 ± 1.3a
79.1 ± 2.0b
16.1 ± 2.9b
65.6 ± 2.5c
12.7 ± 2.8a
47.3 ± 2.5a
9.6 ± 1.1a
58.9 ± 2.3a
12.3 ± 1.3a
67.5 ± 1.8c
14.5 ± 2.6a,b
64.2 ± 2.7c
13.4 ± 1.8a
Effect of addition of FSH and LH in IVM media on FSHR and LHR mRNA expression in cumulus cells (Experiment 2)
Concentration-dependent effect of MG132 from 18–24 h of maturation on subsequent embryonic development (Experiment 3)
Concentration-dependent effects of MG132 added from 18–24 h of maturation on yak embryonic development
No. of oocytes
Cleavage rate (%)
Blastocyst rate (%)
76.8 ± 2.0a
14.1 ± 2.2a
77.0 ± 1.9a
14.7 ± 1.5a
79.8 ± 2.2a
18.1 ± 2.8b
72.1 ± 1.4a,b
12.5 ± 2.2a,c
69.2 ± 1.6b
10.6 ± 1.3c
Fertilization rates of oocytes treated with MG132 from 0–6 or 18–24 h of maturation (Experiment 4)
Effects of timing of MG132 treatment (10 μM) on yak embryonic development
MG132, 0–6 h
MG132, 18–24 h
No. of oocytes
Cleavage rate (%)
Blastocyst rate (%)
39.1 ± 2.5a
11.6 ± 3.1a
33.0 ± 2.0b
9.4 ± 2.9a
77.9 ± 2.6c
19.1 ± 1.3b
75.0 ± 2.0c
15.0 ± 3.2c
Yak oocyte competence for fertilization and ability to support embryonic development was affected by additions of FSH, LH and the proteasomal inhibitor MG132 during the maturation process. The optimal concentration of FSH and LH in IVM media was 5 μg/ml FSH and 50 IU/ml LH. The percentage of cleaved embryos becoming blastocysts could be further improved by MG132, but actions of MG132 depended on the time of addition and the concentration. Yak oocyte competence was improved when 10 μM MG132 was added during the last 6 h maturation (from 18–24 h of maturation) and reduced when added during the first 6 h of maturation.
The mammalian oocytes are surrounded by several layers of cumulus cells, with the corona cell being closest to the oocyte. FSH and LH stimulate cumulus cell expansion, nuclear maturation, cytoplasmic maturation, and improve embryonic development in mice [2, 3], pig , cow , equine  and dog . In previous studies of mice and rats, the cumulus cells had high numbers of FSH receptors, but little or no LH receptors [19–21]. In bovines, it was reported that the FSH receptor and its mRNA were expressed in cumulus cells and granulosa cells, but not the mRNA of the LH receptor . In this study, we observed that an optimal concentration of 5 μg/ml FSH and 50 IU/ml LH in IVM medium increased yak oocyte competence for fertilization and ability to support embryonic development (Table 1), and FSHR and LHR mRNA expressions of cumulus cells. FSH was more effective than LH due to higher FSH receptor levels in cumulus cells of yak oocytes than the levels of the LH receptor. In addition, treatment with FSH in IVM media had greater effect on the increase of FSHR and LHR mRNA expression level than that of LH (Figure 1).
Early in maturation, completion of meiosis I requires inactivation of maturation promoting factor (MPF) through a process mediated by proteasomal cleavage of ubiquitinated cyclin B1 . In bovine, MG132 treatment from 0–6 h of maturation has been reported to increase the proportion of oocytes that were at metaphase I and decrease the number of oocytes that reached metaphase II at the end of maturation . Therefore, inhibition of meiosis is likely a major cause for reduced oocyte competence in bovine oocytes. Inhibition of other proteasome-mediated events early in maturation may also be involved in reduced oocyte competence. For example, in the pig, MG132 can affect expression of genes involved in expansion of the extracellular matrix . Similarly, in this study, we also observed that yak oocyte competence for development after fertilization was significantly reduced by addition of MG132 from 0–6 h of maturation (Table 3).
The finding that treatment of yak COCs with 10 μM MG132 late in maturation improves the percentage of cleaved embryos becoming blastocysts is consistent with other results showing beneficial effects of MG132 on aged mouse oocytes fertilized by intracytoplasmic sperm injection , parthenogenetically activated pig oocytes  and IVM bovine oocytes . Beneficial effects of MG132 on nuclear remodeling, transcript abundance and embryonic development have also been shown for embryos constructed by somatic cell nuclear cloning in mammalian species [10, 25–28]. Optimal results with MG132 were achieved at a concentration of 10 μM – beneficial effects were generally not observed at lower or higher concentrations (Table 2). Similar effects have been seen in mouse, goat, pig and bovine oocytes used for SCNT [25, 29] and IVF . In contrast to the observation by You et al.  in bovine oocytes, inhibition of proteasomes late in maturation can not improve the competence of yak oocyte to cleave in the present study (Tables 2 and 3). The mechanism by which MG132 late in maturation improves competence of the oocyte to support development is likely to involve arrest of processes mediated by proteasomes that ordinarily compromise the oocyte. In bovine oocytes, it was found that MG132 at the end of maturation increased relative expression of six proteins and decreased relative expression of 23 that are potentially important for oocyte competence .
An optimal concentration of FSH and LH improves oocytes competence for development after fertilization in yak. Treatment with MG132 early in maturation reduces fertilization rate and the proportion of oocytes and cleaved embryos that became blastocysts. Conversely, inhibition of proteasomes late in maturation can improve oocytes competence for development after fertilization.
This work was supported by National Key Technology R&D Program (No. 2012 BAD13B06) and Southwest University for Nationalities (12NZYTH07; 2011XWD-S0905).
- Eppig JJ: Coordination of nuclear and cytoplasmic oocyte maturation in eutherian mammals. Reprod Fertil Dev. 1996, 8: 485-489. 10.1071/RD9960485.View ArticlePubMedGoogle Scholar
- Eppig JJ: Gonadotropin stimulation of the expansion of cumulus oophori isolated from mice: general conditions for expansion in vitro. J Exp Zool. 1979, 208: 111-120. 10.1002/jez.1402080112.View ArticlePubMedGoogle Scholar
- Junk SM, Dharmarajan A, Yovich JL: FSH priming improves oocyte maturation, but priming with FSH or hCG has no effect on subsequent embryonic development in an in vitro maturation program. Theriogenology. 2003, 59: 1741-1749. 10.1016/S0093-691X(02)01234-7.View ArticlePubMedGoogle Scholar
- Singh B, Barbe GJ, Armstrong DT: Factors influencing resumption of meiotic maturation and cumulus expansion of porcine oocyte-cumulus cell complexes in vitro. Mol Reprod Dev. 1993, 36: 113-119. 10.1002/mrd.1080360116.View ArticlePubMedGoogle Scholar
- Zuelke KA, Brackett BG: Luteinizing hormone-enhanced in vitro maturation of bovine oocytes with and without protein supplementation. Biol Reprod. 1990, 43: 784-787. 10.1095/biolreprod43.5.784.View ArticlePubMedGoogle Scholar
- Dell'Aquila ME, Caillaud M, Maritato F, Martoriati A, Gérard N, Aiudi G, Minoia P, Goudet G: Cumulus expansion, nuclear maturation and connexin 43, cyclooxygenase-2 and FSH receptor mRNA expression in equine cumulus-oocyte complexes cultured in vitro in the presence of FSH and precursors for hyaluronic acid synthesis. Reprod Biol Endocrinol. 2004, 2: 44-10.1186/1477-7827-2-44.PubMed CentralView ArticlePubMedGoogle Scholar
- Lee HS, Seo YI, Yin XJ, Cho SG, Lee SS, Kim NH, Cho SK, Kong IK: Effect of follicle stimulation hormone and luteinizing hormone on cumulus cell expansion and in vitro nuclear maturation of canine oocytes. Reprod Dom Anim. 2007, 42: 561-565. 10.1111/j.1439-0531.2006.00818.x.View ArticleGoogle Scholar
- Calder MD, Caveney AN, Smith LC, Watson AJ: Responsiveness of bovine cumulus- oocyte-complexes (COC) to porcine and recombinant human FSH, and the effect of COC quality on gonadotropin receptor and Cx43 marker gene mRNAs during maturation in vitro. Reprod Biol Endocrinol. 2003, 1: 14-10.1186/1477-7827-1-14.PubMed CentralView ArticlePubMedGoogle Scholar
- Ono T, Mizutani E, Li C, Yamagata K, Wakayama T: Offspring from intracytoplasmic sperm injection of aged mouse oocytes treated with caffeine or MG132. Genesis. 2011, 49: 460-471. 10.1002/dvg.20756.View ArticlePubMedGoogle Scholar
- You J, Kim J, Lee H, Hyun SH, Hansen PJ, Lee E: MG132 treatment during oocyte maturation improves embryonic development after somatic cell nuclear transfer and alters oocyte and embryo transcript abundance in pigs. Mol Reprod Dev. 2012, 79: 41-50. 10.1002/mrd.21402.View ArticlePubMedGoogle Scholar
- You J, Lee E, Bonilla L, Francis J, Koh J, Blocket J, Chen S, Hansen PJ: Treatment with the proteasome inhibitor MG132 during the end of oocyte maturation improves oocyte competence for development after fertilization in cattle. PLoS One. 2012, 7: e48613-10.1371/journal.pone.0048613.PubMed CentralView ArticlePubMedGoogle Scholar
- Wiener G, Han JL, Long RJ: The Yak. 2003, Bangkok: The Regional Office for Asia and the Pacific of the Food and Agriculture Organization of the United Nations, 2Google Scholar
- Zi XD, Yin RH, Chen SW, Liang GN, Zhang DW: Developmental competence of embryos derived from reciprocal in vitro fertilization between yak (Bos grunniens) and cattle (Bos taurus). J Reprod Dev. 2009, 55: 480-483. 10.1262/jrd.20202.View ArticlePubMedGoogle Scholar
- Guo X, Ding XZ, Pei J, Bao PJ, Liang CN, Chu M, Yan P: Efficiency of in vitro embryo production of yak (Bos grunniens) cultured in different maturation and culture conditions. J Appl Anim Sci. 2012, 40: 323-329.Google Scholar
- Tervit HR, Whittingham DG, Rowson LEA: Successful culture in vitro of sheep and cattle ova. J Reprod Fertil. 1972, 30: 487-493.Google Scholar
- Zi XD, Lu H, Yin RH, Chen SW: Development of embryos after in vitro fertilization of bovine oocytes with sperm from either yaks (Bos grunniens) or cattle (Bos taurus). Anim Reprod Sci. 2008, 108: 208-215. 10.1016/j.anireprosci.2007.08.005.View ArticlePubMedGoogle Scholar
- Zi XD, Chen DW, Wang HM: Molecular characterization, mRNA expression of prolactin receptor (PRLR) gene during pregnancy, nonpregnancy in the yak (Bos grunniens). Gen Comp Endocrinol. 2012, 175: 384-388. 10.1016/j.ygcen.2011.12.004.View ArticlePubMedGoogle Scholar
- Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29: 2002-2007.View ArticleGoogle Scholar
- Vanderhyden BC, Armstrong DT: Role of cumulus cells and serum on the in vitro maturation, fertilization, and subsequent development of rat oocytes. Biol Reprod. 1989, 40: 720-728. 10.1095/biolreprod40.4.720.View ArticlePubMedGoogle Scholar
- Peng XR, Hsueh AJ, LaPolt PS, Bjersing L, Ny T: Localization of luteinizing hormone receptor messenger ribonucleic acid expression in ovarian cell types during follicle development and ovulation. Endocrinology. 1991, 129: 3200-3207. 10.1210/endo-129-6-3200.View ArticlePubMedGoogle Scholar
- Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM: Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol. 1999, 13: 1035-1048. 10.1210/mend.13.6.0310.View ArticlePubMedGoogle Scholar
- van Tol HT, van Eijk MJ, Mummery CL, van den Hurk R, Bevers MM: Influence of FSH and hCG on the resumption of meiosis of bovine oocytes surrounded by cumulus cells connected to membrana granulosa. Mol Reprod Dev. 1996, 45: 218-224. 10.1002/(SICI)1098-2795(199610)45:2<218::AID-MRD15>3.0.CO;2-X.View ArticlePubMedGoogle Scholar
- Karabinova P, Kubelka M, Susor A: Proteasomal degradation of ubiquitinated proteins in oocyte meiosis and fertilization in mammals. Cell Tissue Res. 2011, 346: 1-9. 10.1007/s00441-011-1235-1.View ArticlePubMedGoogle Scholar
- Nagyova E, Scsukova S, Nemcova L, Mlynarcikova A, Yi YJ, Sutovsky M, Sutovsky PNE: Inhibition of proteasomal proteolysis affects expression of extracellular matrix components and steroidogenesis in porcine oocyte-cumulus complexes. Domest Anim Endocrinol. 2012, 42: 50-62. 10.1016/j.domaniend.2011.09.003.View ArticlePubMedGoogle Scholar
- Gao S, Han Z, Kihara M, Adashi E, Latham KE: Protease inhibitor MG132 in cloning: no end to the nightmare. Trends Biotechnol. 2005, 23: 66-68. 10.1016/j.tibtech.2004.12.007.View ArticlePubMedGoogle Scholar
- Wu YG, Zhou P, Lan GC, Wang G, Luo MJ, Tan JH: The effects of delayed activation and MG132 treatment on nuclear remodeling and preimplantation development of embryos cloned by electrofusion are correlated with the age of recipient cytoplasts. Cloning Stem Cells. 2007, 9: 417-431. 10.1089/clo.2006.0023.View ArticlePubMedGoogle Scholar
- Mizumoto S, Kato Y, Tsunoda Y: The developmental potential of parthenogenetic and somatic cell nuclear-transferred rat oocytes in vitro. Cloning Stem Cells. 2008, 10: 4453-4459.View ArticleGoogle Scholar
- Nakajima N, Inomata T, Kashiwazaki N: Treatment with proteasome inhibitor MG132 during cloning improves survival and pronuclear number of reconstructed rat embryos. Cloning Stem Cells. 2008, 10: 461-468. 10.1089/clo.2008.0038.View ArticlePubMedGoogle Scholar
- Whitworth KM, Li R, Spate LD, Wax DM, Rieke A, Whyte JJ, Manandhar G, Sutovsky M, Green JA, Sutovsky P, Prather RS: Method of oocyte activation affects cloning efficiency in pigs. Mol Reprod Dev. 2009, 76: 490-500. 10.1002/mrd.20987.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.